mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.031 |
0.5 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
KU-55933 |
GDSC1000 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.17 |
0.6 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.6 |